Back
Vir Biotechnology, Inc. 10K Form
Sell
35
VIR
Vir Biotechnology, Inc.
Last Price:
$6.51
Seasonality Move:
40.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VIR News And Ratings
See the #1 stock for the next 7 days that we like better than VIR
VIR Financial Statistics
Sales & Book Value
| Annual Sales: | $74.2M |
|---|---|
| Cash Flow: | $-167.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.73 |
| Price / Book: | 1.14 |
Profitability
| EPS (TTM): | -3.62010 |
|---|---|
| Net Income (TTM): | $-499.7M |
| Gross Margin: | $58.8M |
| Return on Equity: | -48.24% |
| Return on Assets: | -38.78% |
Vir Biotechnology, Inc. Earnings Forecast
Key Vir Biotechnology, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for VIR is 79.24%.
-
The Selling, General & Administrative Expenses for VIR have been equal to 160.41% of Gross Profit Margin.
-
The Research & Development expenses have been 624.20% of Revenue.
-
The Net Earning history of VIR is -703.40% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 2 years.
Vir Biotechnology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VIR |
| CUSIP: | 92764N |
| Website: | vir.bio |
Debt
| Debt-to-Equity Ratio: | 0.13 |
|---|---|
| Current Ratio: | 7.25 |
| Quick Ratio: | 6.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VIR Technical Analysis vs Fundamental Analysis
Sell
35
Vir Biotechnology, Inc. (VIR)
is a Sell
Is Vir Biotechnology, Inc. a Buy or a Sell?
-
Vir Biotechnology, Inc. stock is rated a SellThe current Vir Biotechnology, Inc. [VIR] share price is $6.50. The Score for VIR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.